The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
The three biggest pharmacy benefit managers made more than $7.3 billion over five years marking up the prices of specialty ...
The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...